BiotechTube
Home/Tolremo Therapeutics/Julie M. Cherrington, PhD
JM

Julie M. Cherrington, PhD

Chair of the Board

Tolremo Therapeutics

Roles

Chair of the BoardatTolremo Therapeutics
Board ChairatActym Therapeutics

Therapeutic Areas

Oncology

Tolremo Therapeutics Pipeline

DrugIndicationPhase
TT125-802Solid tumors and hematological malignancies (for prevention of resistance)Phase 1

Leadership Team at Tolremo Therapeutics

SF
Stefanie Flückiger-Mangual, PhD
CEO
AC
Alessandra Cesano, MD, PhD
Chief Medical Officer
JC
Jessica Corson
Chief Business Officer
CE
Claudia Escher, PhD
COO
View full Tolremo Therapeutics profile